CareLit · DOI-Nachweis · Pneumologie
Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium + Olodaterol In Patients With COPD By Initial Disease Severity
DOI 10.1055/s-0036-1572055
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Haensel, S Korn, R Buhl, L Grönke, L Korducki, VC Amatto, GT Ferguson, R Abrahams
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Rationale: Tiotropium (T), a long-acting muscarinic antagonist, and olodaterol (O), a long-acting β2-agonist (both administered once-daily), have been studied as a once-daily fixed-dose combination (FDC). Data from two, large clinical studies demonstrated that T+O FDC significantly improved lung function and symptoms over the monotherapies in patients with moderate to very severe COPD.1 This analysis was conducted t…
Zitieren
Zitierempfehlung
M Haensel, S Korn, R Buhl, L Grönke, L Korducki, VC Amatto, GT Ferguson, R Abrahams (2016) Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium + Olodaterol In Patients With COPD By Initial Disease Severity. Pneumologie (02). https://doi.org/10.1055/s-0036-1572055
Mit CareLit weiterarbeiten